Envista
David Coggins is a seasoned professional with extensive experience in customer intelligence analysis, particularly within CRM environments. Currently serving as a Sr. Customer Intelligence Analyst at Envista Holdings Corporation since May 2023, David is responsible for translating business requirements into IT specifications and managing CRM implementations, training, and process improvements. Prior to this role, David held various positions at KaVo Kerr, including Microsoft Dynamics Trainer and Power User, and Quality Analyst, where responsibilities included training associates and monitoring call quality. Experience also includes positions at DEXIS as a Senior Technical Analyst and Implementation Analyst, and roles at Wipro BPO and Research Solutions Group focused on technical support and quality analysis. David holds an AA in Applied Science Information Technology from Clayton State University and possesses a strong background in data quality improvement, project management, and technical support.
This person is not in any teams
This person is not in any offices
Envista
7 followers
Envista Holdings Corporation is a dental products company. The Company provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone. The Company operates through two segments: Specialty Products & Technologies, and Equipment & Consumables. Its Specialty Products & Technologies segment develops, manufactures and markets dental implant systems, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners and lab products. Its Equipment & Consumables segment develops, manufactures and markets dental equipment and supplies used in dental offices, including digital imaging systems, software and other visualization/magnification systems; treatment units and other dental practice equipment; endodontic systems and related consumables; restorative materials and instruments, rotary burs, impression materials, bonding agents and cements and infection prevention products.